EDGAR Filing Documents for 0001445305-14-001051

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001445305-14-001051

Filing Date

2014-03-14

Accepted

2014-03-14 16:59:32

Documents

Period of Report

2013-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	navb1231201310k.htm	10-K	2899147
2	EXHIBIT 3.1	navb12312013ex3-1.htm	EX-3.1	88624
3	EXHIBIT 21.1	navb12312013ex21-1.htm	EX-21.1	5339
4	EXHIBIT 21.4	navb12312013ex21-4.htm	EX-21.4	12047
5	EXHIBIT 23.1	navb12312013ex23-1.htm	EX-23.1	3745
6	EXHIBIT 31.1	navb12312013ex31-1.htm	EX-31.1	9881
7	EXHIBIT 31.2	navb12312013ex31-2.htm	EX-31.2	9904
8	EXHIBIT 32.1	navb12312013ex32-1.htm	EX-32.1	5166
9	EXHIBIT 32.2	navb12312013ex32-2.htm	EX-32.2	5185
16		navb123120_chart-37866.jpg	GRAPHIC	65832
	Complete submission text file	0001445305-14-001051.txt		12727874

Data Files

Seq	Description	Document	Type	Size
10	XBRL INSTANCE DOCUMENT	navb-20131231.xml	EX-101.INS	1512423
11	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	navb-20131231.xsd	EX-101.SCH	75005
12	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	navb-20131231_cal.xml	EX-101.CAL	87942
13	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	navb-20131231_def.xml	EX-101.DEF	389012
14	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	navb-20131231_lab.xml	EX-101.LAB	943292
15	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	navb-20131231_pre.xml	EX-101.PRE	576609

Mailing Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017

Business Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017 6147937500

NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)